![]() ![]() See the frequently asked questions for more information or contact with other questions. New users of the CDER NextGen Portal must register for an account. Portal for submitting orphan drug designation requests By emailing the required information to By mailing the required information to:Īttention: Orphan Drug Designation Program.Sponsors may submit orphan drug designation requests one of three ways: How to submit orphan drug designation requests See the orphan drug designations and approvals database for more information. Drugs for rare diseases go through the same rigorous scientific review process as any other drug for approval or licensing. Orphan drug designation is a separate process from seeking approval or licensing. Sponsors requesting designation of the same drug for the same rare disease or condition as a previously designated product must submit their own data and information to support their designation request. Sponsors seeking orphan drug designation for a drug must submit a request for designation to the agency. Potential seven years of market exclusivity after approval.Tax credits for qualified clinical trials.Orphan drug designation qualifies sponsors for incentives including: The FDA has authority to grant orphan drug designation to a drug or biological product to prevent, diagnose or treat a rare disease or condition. Supporting the development and evaluation of new treatments for rare diseases is a key priority for the FDA. ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |